Free Newsletter
Asian countries push big pharma boom
We already knew Asia was the place to be for pharmaceuticals these days, but it's nice to have our instincts confirmed by experts. PricewaterhouseCoopers has released a study based on interviews with 185 top pharma execs in the Asia-Pacific region. The verdict? Not only are China, India, Singapore and their neighbors poised to become huge pharmaceuticals consumers, but big producers as well.
Asian countries are falling all over themselves to attract pharmaceuticals manufacturing and development, with China and India leading the way. Western companies are plowing money into facilities in China, and in India, the clinical trials market ($150 million) and contract manufacturing ($350 million) are poised to reach $1 billion each by 2010. But while China is focused almost solely on generics, Indian companies are doing their own development. Hey, a little competition never hurts.
- here's the report from the Bangkok Post
- check out this link to the report
Related Articles:
Singapore to spend $8B on biotech R&D. Report
China pushes drug development as R&D soars. Report
India's biotech future is bright. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: